RayzeBio, a wholly-owned subsidiary of Bristol Myers Squibb, seeks a Director, Biology Group Lead to drive discovery and validation of novel radiopharmaceutical targets. You will shape biology strategy, lead a multidisciplinary team, and guide IND-enabling candidate selection to advance transformative cancer therapies.
You will oversee target identification, validation, and quantitative pharmacology while collaborating with imaging, radiochemistry, DMPK, and clinical development teams to
#J-18808-LjbffrBiology Group Lead – Radiopharmaceutical Oncology in northern at Unknown Company
This position is listed as full time and onsite.